Investment fund to support nascent or early-stage spin-out companies developing therapeutics for major diseases.
LifeArc is a UK medical research charity that supports the research, translation and commercialisation of innovative treatments and diagnostics that address unmet medical needs, including rare diseases.
The LifeArc Seed Fund is a £25 million venture investment fund to support nascent and early-stage spin-out companies developing therapeutics for major human diseases. The Seed Fund forms part of LifeArc’s strategy for aiding the delivery of viable therapeutics to market and will work in conjunction with its Philanthropic Fund to catalyse translational development of therapeutics for rare diseases.
Funded plans need to demonstrate the ability to attract follow-on investment on achievements of their milestones.